Disease
Solid Tumors
Solid Tumors clinical programs
Coverage in progress. The assets here come from their companies' published pipelines. AssetMemo has not yet run its full census of every drug in development for Solid Tumors, so this list is not complete.
Market size not yet sourced. How markets are sized ↗
Indications
Solid Tumors
Market size not yet sourced
All-stage · US
Advanced Nectin-4 Expressing Solid Tumors
Market size not yet sourced
All-stage · US
Advanced Solid Tumors
Market size not yet sourced
All-stage · US
Advanced Refractory Solid Tumors
Market size not yet sourced
All-stage · US
HER2-Positive Advanced Solid Tumors
Market size not yet sourced
All-stage · US
Advanced or Metastatic Solid Tumors
Market size not yet sourced
All-stage · US
Advanced ROR1-Expressing Solid Tumors and Lymphomas
Market size not yet sourced
All-stage · US